drugset / Trial / NCT07331818
Luspatercept in Patients Affected With Rare Inherited Anemias
NaSingle-groupOpen-labelTreatment
Summary
This is a prospective multicenter phase II basket trial evaluating Luspatercept in patients affected with rare inherited anemias
Timeline
- Start
- 2026-01-15
- Primary completion
- 2028-09
- Completion
- 2029-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Luspatercept | Protein / enzyme biologic | 1 mg/kg | Other |